logo
logo
Sign in

2018-2023 Global Overactive Bladder Treatment Market Trend, Analysis & Overview

avatar
grace walker
2018-2023 Global Overactive Bladder Treatment Market Trend, Analysis & Overview

The Global Overactive Bladder Treatment Market is expected to register a CAGR of about 2.9% over the forecast period, 2018-2023. The overactive bladder treatments includes various therapies like, anticholinergics, mirabegron, etc., that are used to treat the sudden, involuntary contraction of the muscle in the urinary bladder wall leading to urinary urgency, frequency, nocturia, and urge-incontinence.

Aging Population and Rising Incidence of Diseases Characterized By OAB 

In 2017, there were approximately 950 million people who were 60 years old or above, comprising 13% of the global population, and is growing by about 3% every year. Incontinence generally increases with aging. As per a global population-based survey, the estimated prevalence of overactive bladder (OAB) in Europe and Canada was found to be 12.8% in women and 10.8% in men. OAB has a major negative impact on quality of life and health of the aged population. With the increasing burden of OAB, along with other urinary diseases, the growth of the overactive bladder treatment market is likely to be high. Other factors, such as the development of innovative intravesical therapies and aggressive marketing by pharmaceuticals companies, are also expected to expand the market.

Undesired Systemic Effects of the Current OAB Treatments

Anticholinergic have been linked to the burden to dementia or Alzheimer’s disease in a few recent studies. In a recent publication by SL Gray, 3434 participants were studied and a 10-year cumulative dose response relationship was found to exist between the usage of anticholinergic drugs and the risk of developing dementia. Anticholinergic has also been linked with increased mortality and cardiovascular diseases. These factors may deter healthcare providers from using these treatment options. Also the increasing awareness about these side effects among users will lead to the slowdown of the growth of this market.

Get a PDF sample of this report @ http://www.orbisresearch.com/contacts/request-sample/2213803?utm_source=km

North America to Dominate the Overactive Bladder Treatment Market

North America has dominated the overactive bladder treatment market, which can be primarily attributed to its well-established healthcare industry which has favorable reimbursement of overactive bladder treatment, growing prevalence of the disease with rising age, and the presence of major players. Asia-Pacific region is expected to witness the highest CAGR during the forecast period, due to rising prevalence of bladder overactivity, increasing geriatric population, rising healthcare expenditure, and growing awareness of overactive bladder.

Major Players:

Allergan Plc., Apotex Inc., Astellas Pharma Inc., Aurobindo Pharma Limited, Cogentix Medical Inc., Endo International Plc, Hisamitsu Pharmaceutical Co. Inc., Intas Pharmaceuticals Ltd, Johnson & Johnson, Macleods Pharmaceuticals Ltd, Medtronic Plc, Mylan Nv, Pfizer Inc., Sanofi, And Teva Pharmaceutical Industries Limited, Amongst Others.

Reasons to Purchase Overactive Bladder Treatment Market Report

  • Current and future overactive bladder treatment market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in Excel)

Customization of Overactive Bladder Treatment Market Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

 Enquiry before buying report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2213803?utm_source=km

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +912064101019

collect
0
avatar
grace walker
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more